Halozyme Therapeutics Inc (HALO)
55.27
-0.67
(-1.20%)
USD |
NASDAQ |
Jan 22, 16:00
55.27
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Price: 55.27 for Jan. 22, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
Biomarin Pharmaceutical Inc | 62.04 |
Amicus Therapeutics Inc | 9.545 |
Lexicon Pharmaceuticals Inc | 0.85 |
Novavax Inc | 8.845 |
Kura Oncology Inc | 7.855 |
Price Related Metrics
PE Ratio | 18.30 |
PS Ratio | 7.575 |
PEG Ratio | 0.3018 |
Price to Book Value | 15.53 |
Price to Free Cash Flow | 18.27 |
Earnings Yield | 5.46% |
Market Cap | 7.032B |
PEGY Ratio | 0.3018 |
Operating PE Ratio | 15.04 |
Normalized PE Ratio | 19.18 |